Literature DB >> 8498426

Meconium testing for cocaine metabolite: prevalence, perceptions, and pitfalls.

S S Rosengren1, D B Longobucco, B A Bernstein, S Fishman, E Cooke, F Boctor, S C Lewis.   

Abstract

OBJECTIVES: We determined the prevalence of prenatal cocaine use in a racially mixed sample of urban and suburban mothers and correlated its use with maternal demographics and newborn measurements. STUDY
DESIGN: Meconium from 621 consecutive newborns delivered at two university-affiliated urban hospitals were assayed for benzoylecgonine. Maternal and infant characteristics were linked anonymously with the results. Statistical analysis included t test, Fisher's exact test, Duncan's multiple range analysis, and analysis of covariance, with a value of p < 0.05 considered significant.
RESULTS: We found that 3.4% of meconium samples had benzoylecgonine levels exceeding 0.1 micrograms/ml. Its presence was statistically correlated with maternal and neonatal characteristics. A nurse's opinion of cocaine use was correct 22% of the time.
CONCLUSIONS: Prenatal cocaine use was statistically associated with multiparity, multigravidity, late-onset and clinic-based prenatal care, public assistance, nonwhite race, and low academic achievement. A nurse's opinion was a poor predictor of maternal cocaine use. Cocaine-exposed infants were significantly smaller, and this correlated best with nonwhite background.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8498426     DOI: 10.1016/s0002-9378(11)90780-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  1 in total

Review 1.  Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure. Problems of dose and confounding.

Authors:  D A Frank; M Augustyn; B S Zuckerman
Journal:  Ann N Y Acad Sci       Date:  1998-06-21       Impact factor: 5.691

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.